February 2021 tender notification
PHARMAC has resolved to award tenders for Principal Supply Status for some products included in the 2020/21 Invitation to Tender, dated 2 November 2020.
Tender results
PHARMAC has resolved to award tenders for Principal Supply Status for some products included in the 2020/21 Invitation to Tender, dated 2 November 2020.
Some of the pharmaceuticals that will be delisted when the period of Sole Subsidised Supply/Hospital Supply Status commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts. PHARMAC will continue to subsidise those pharmaceuticals accordingly until such time as those pharmaceuticals are delisted.
Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes
Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to submit a Notification of Product Changes (NOPC) form to PHARMAC, the Pharmacy Guild and the NZULM by:
- For new listings, by 4pm on 12 March 2021 or the 5th of the month prior to listing, whichever is earlier
- For price changes, by 4pm on the 12th of the month prior to the date of subsidy change
PHARMAC cannot list a product (and pharmacies cannot claim) without this information.
More information about this process and NOPC forms can be found on our website.
Suppliers are required to ensure that a Pharmacode has been obtained from the Pharmacy Guild of New Zealand(external link) and that a CTPP code has been obtained from the New Zealand Universal List of Medicines(external link). Pharmacodes and CTPP codes must be provided to PHARMAC by the 5th of the month prior to the date of listing, or the date above (whichever is earliest).
PHARMAC cannot list a product (and pharmacies cannot claim) without the correct Pharmacode.
2020/21 Tender – Principal Supply Status applies until 30 June 2024
Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule
1. Tenders awarded to currently listed pharmaceuticals where no other brand is listed.
The decisions were as follows:
|
Chemical name |
Presentation; |
Current |
New |
Principal Supply brand |
Date of subsidy change |
Principal Supply date |
|
|---|---|---|---|---|---|---|---|
|
Aciclovir |
Eye oint 3%, 4.5g OP tube |
$14.92 |
$14.88 |
ViruPOS (AFT) |
1 April 2021 |
1 Septemer 2021 |
|
|
Atorvastatin |
Tab 10 mg, 500 tablet, bottle |
$6.96 |
$6.16 |
Lorstat (Mylan) |
1 July 2021 |
1 December 2021 |
|
|
Atorvastatin |
Tab 20 mg, 500 tablet, bottle |
$9.99 |
$9.24 |
Lorstat (Mylan) |
1 July 2021 |
1 December 2021 |
|
|
Atorvastatin |
Tab 40 mg, 500 tablet, bottle |
$15.93 |
$14.92 |
Lorstat (Mylan) |
1 July 2021 |
1 December 2021 |
|
|
Atorvastatin |
Tab 80 mg, 500 tablet, bottle |
$27.19 |
$26.54 |
Lorstat (Mylan) |
1 July 2021 |
1 December 2021 |
|
|
Baclofen1 |
Inj 2 mg per 5 ml, 5 ml ampoule, 5 ampoule pack |
$372.98 |
$306.82 |
Medsurge (Medsurge) |
1 July 2021 |
1 December 2021 |
|
|
Betamethasone dipropionate with calcipotriol |
Gel 500 mcg with calcipotriol 50 mcg per g, 60 g OP bottle |
$52.24 |
$39.35 |
Daivobet (LEO Pharma) |
1 July 2021 |
1 December 2021 |
|
|
Betamethasone dipropionate with calcipotriol |
Oint 500 mcg with calcipotriol 50 mcg per g, 30 g OP tube |
$19.95 |
$15.90 |
Daivobet (LEO Pharma) |
1 July 2021 |
1 December 2021 |
|
|
Bisacodyl |
Suppos 10 mg, 10 suppository pack |
$3.74 |
$3.69 |
Lax-Suppositories (AFT) |
1 July 2021 |
1 December 2021 |
|
|
Bosentan |
Tab 62.5 mg, 60 tablet, blister pack |
$141.00 |
$119.85 |
Bosentan Dr Reddy’s |
1 July 2021 |
1 December 2021 |
|
|
Bosentan |
Tab 125 mg, 60 tablet, blister pack |
$141.00 |
$119.85 |
Bosentan Dr Reddy’s |
1 July 2021 |
1 December 2021 |
|
|
Brinzolamide |
Eye drops 1%, 5 ml OP dropper bottle |
$9.77 |
$7.30 |
Azopt (Novartis) |
1 April 2021 |
1 September 2021 |
|
|
Candesartan cilexetil |
Tab 4 mg, 90 tablet, bottle |
$1.90 |
$2.00 |
Candestar (Mylan) |
1 July 2021 |
1 December 2021 |
|
|
Candesartan cilexetil |
Tab 8 mg, 90 tablet, bottle |
$2.28 |
$2.28 |
Candestar (Mylan) |
1 July 2021 |
1 December 2021 |
|
|
Candesartan cilexetil |
Tab 16 mg, 90 tablet, bottle |
$3.67 |
$3.31 |
Candestar (Mylan) |
1 July 2021 |
1 December 2021 |
|
|
Candesartan cilexetil |
Tab 32 mg, 90 tablet, bottle |
$6.39 |
$5.26 |
Candestar (Mylan) |
1 July 2021 |
1 December 2021 |
|
|
Ciprofloxacin1 |
Eye drops 0.3%, 5 ml OP dropper bottle |
$12.15 |
$9.73 |
Ciprofloxacin Teva (Teva) |
1 June 2021 |
1 November 2021 |
|
|
Crotamiton |
Crm 10%, 20 g OP tube |
$3.29 |
$3.29 |
Itch-Soothe (AFT) |
1 July 2021 |
1 December 2021 |
|
|
Cyclizine hydrochloride |
Tab 50 mg, 10 tablet, blister pack |
$0.55 |
$0.49 |
Nausicalm (AFT) |
1 July 2021 |
1 December 2021 |
|
|
Fluorouracil sodium |
Crm 5%, 20 g OP tube |
$7.95 |
$6.95 |
Efudix (iNova) |
1 July 2021 |
1 December 2021 |
|
|
Fluticasone propionate |
Metered aqueous nasal spray, 50 mcg |
$1.98 |
$1.98 |
Flixonase Hayfever |
1 July 2021 |
1 December 2021 |
|
|
Glyceryl trinitrate |
Oint 0.2%, 30 g OP tube |
$22.00 |
$22.00 |
Rectogesic (Care Pharmaceuticals) |
1 April 2021 |
1 September 2021 |
|
|
Hydrocortisone |
Inj 100 mg vial, 1 vial pack |
$5.30 |
$4.38 |
Solu-Cortef (Pfizer) |
1 June 2021 |
1 November 2021 |
|
|
Hydrocortisone butyrate |
Oint 0.1%, 100 g OP tube |
$13.70 |
$10.28 |
Locoid (LEO Pharma) |
1 July 2021 |
1 December 2021 |
|
|
Hydrocortisone butyrate |
Milky emul 0.1%, 100 ml OP bottle |
$13.70 |
$12.33 |
Locoid Crelo |
1 July 2021 |
1 December 2021 |
|
|
Hydrocortisone butyrate |
Scalp lotn 0.1%, 100 ml OP bottle |
$7.30 |
$6.57 |
Locoid (LEO Pharma) |
1 July 2021 |
1 December 2021 |
|
|
Hydrocortisone with miconazole |
Crm 1% with miconazole nitrate 2%, 15 g OP tube |
$2.00 |
$1.89 |
Micreme H (Mylan) |
1 July 2021 |
1 December 2021 |
|
|
Lansoprazole |
Cap 15 mg, 100 capsule, bottle |
$4.58 |
$4.20 |
Lanzol Relief (Mylan) |
1 July 2021 |
1 December 2021 |
|
|
Lansoprazole |
Cap 30 mg, 100 capsule, bottle |
$5.41 |
$5.26 |
Lanzol Relief (Mylan) |
1 July 2021 |
1 December 2021 |
|
|
Lithium carbonate |
Tab long-acting 400 mg, 100 tablet, |
$72.00 |
$72.00 |
Priadel (Clinect NZ) |
1 April 2021 |
1 September 2021 |
|
|
Lorazepam |
Tab 1 mg, 250 tablet, bottle |
$9.72 |
$9.72 |
Ativan (Aspen Pharma) |
1 July 2021 |
1 December 2021 |
|
|
Lorazepam |
Tab 2.5 mg, 100 tablet, bottle |
$12.50 |
$12.50 |
Ativan (Aspen Pharma) |
1 July 2021 |
1 December 2021 |
|
|
Miconazole |
Oral gel 20 mg per g, 40 g OP tube |
$4.74 |
$4.74 |
Decozol (AFT) |
1 July 2021 |
1 December 2021 |
|
|
Oxycodone hydrochloride |
Cap immediate-release 5 mg, 20 capsule, |
$1.88 |
$1.88 |
OxyNorm (MundiPharma) |
1 July 2021 |
1 December 2021 |
|
|
Oxycodone hydrochloride |
Cap immediate-release 10 mg, 20 capsule, |
$3.32 |
$3.32 |
OxyNorm (MundiPharma) |
1 July 2021 |
1 December 2021 |
|
|
Oxycodone hydrochloride |
Cap immediate-release 20 mg, 20 capsule, |
$5.81 |
$5.23 |
OxyNorm (MundiPharma) |
1 July 2021 |
1 December 2021 |
|
|
Oxycodone hydrochloride |
Oral liq 5 mg per 5 ml, 250 ml bottle |
$11.20 |
$11.20 |
OxyNorm (MundiPharma) |
1 April 2021 |
1 Septemebr 2021 |
|
|
Prednisolone |
Oral liq 5 mg per ml, 30 ml OP bottle |
$6.00 |
$6.00 |
Redipred |
1 July 2021 |
1 December 2021 |
|
|
Riluzole |
Tab 50 mg, 56 tablet, blister pack |
$130.00 |
$130.00 |
Rilutek (Sanofi) |
1 July 2021 |
1 December 2021 |
|
|
Sodium fusidate [fusidic acid] |
Crm 2%, 5 g OP tube |
$1.59 |
$1.59 |
Foban (AFT) |
1 July 2021 |
1 December 2021 |
|
|
Sodium fusidate [fusidic acid] |
Oint 2%, 5 g OP tube |
$1.59 |
$1.59 |
Foban (AFT) |
1 July 2021 |
1 December 2021 |
|
|
Sodium hyaluronate [hyaluronic acid] |
Eye drops 1 mg per ml, 10 ml OP dropper bottle |
$22.00 |
$13.85 |
Hylo-Fresh (AFT) |
1 August 2021 |
1 January 2022 |
|
|
Solifenacin succinate |
Tab 5 mg, 30 tablet, blister pack |
$3.00 |
$2.05 |
Solifenacin Mylan (Mylan) |
1 July 2021 |
1 December 2021 |
|
|
Solifenacin succinate |
Tab 10 mg, 30 tablet, blister pack |
$5.50 |
$3.72 |
Solifenacin Mylan (Mylan) |
1 July 2021 |
1 December 2021 |
|
|
Valganciclovir |
Tab 450 mg, 60 tablet, bottle |
$225.00 |
$132.00 |
Valganciclovir Mylan (Mylan) |
1 July 2021 |
1 December 2021 |
|
|
Zoledronic acid |
Inj 4 mg per 5 ml, vial, 1 vial pack |
$38.03 |
$18.00 |
Zoledronic Acid (Mylan) |
1 July 2021 |
1 December 2021 |
|
|
1 This product will be supplied at the Price from the 1st day of the month prior to the listing date, as per Schedule 5, clause 3.1 (b)(II) of the 2020/21 Invitation To Tender. |
|
||||||
See table 3 below for changes to Section B of the Pharmaceutical Schedule in relation to bendamustine hydrochloride.
2. Tenders awarded to pharmaceuticals where at least one other brand is listed.
The decisions were as follows:
|
Chemical name |
Presentation; |
Current |
New |
Principal Supply brand (Supplier) |
Date of listing |
Principal Supply Status date |
Brand (Supplier) affected by delisting |
|---|---|---|---|---|---|---|---|
|
Acarbose |
Tab 50 mg, 90 tablet, blister pack |
$10.47 |
$8.95 |
Accarb (Mylan) |
1 July 2021 |
1 December 2021 |
Glucobay (Bayer) |
|
Acarbose |
Tab 100mg, 90 tablet, blister pack |
$20.23 |
$15.29 |
Accarb (Mylan) |
1 July 2021 |
1 December 2021 |
Glucobay (Bayer) |
Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule. Tenders awarded to currently listed pharmaceuticals where no other brand is listed
The decisions were as follows:
3. Tenders awarded to currently listed pharmaceuticals where no other brand is listed.
|
Chemical name |
Presentation; |
Current |
New |
Principal Supply brand |
DV |
Date of subsidy change |
Principal Supply date |
|
|---|---|---|---|---|---|---|---|---|
|
Aciclovir |
Eye oint 3%, 4.5 g tube |
$14.92 |
$14.88 |
ViruPOS (AFT) |
5% |
1 April 2021 |
1 September 2021 |
|
|
Amikacin |
Inj 250 mg per ml, 2 ml vial, 5 vial pack |
$265.00 |
$199.95 |
DBL Amikacin (Pfizer) |
5% |
1 July 2021 |
1 December 2021 |
|
|
Atorvastatin |
Tab 10 mg, 500 tablet, bottle |
$6.96 |
$6.16 |
Lorstat (Mylan) |
5% |
1 July 2021 |
1 December 2021 |
|
|
Atorvastatin |
Tab 20 mg, 500 tablet, bottle |
$9.99 |
$9.24 |
Lorstat (Mylan) |
5% |
1 July 2021 |
1 December 2021 |
|
|
Atorvastatin |
Tab 40 mg, 500 tablet, bottle |
$15.93 |
$14.92 |
Lorstat (Mylan) |
5% |
1 July 2021 |
1 December 2021 |
|
|
Atorvastatin |
Tab 80 mg, 500 tablet, bottle |
$27.19 |
$26.54 |
Lorstat (Mylan) |
5% |
1 July 2021 |
1 December 2021 |
|
|
Baclofen2 |
Inj 2 mg per ml, 5 ml ampoule, 5 ampoule pack |
$372.98 |
$306.82 |
Medsurge (Medsurge) |
5% |
1 July 2021 |
1 December 2021 |
|
|
Bendamustine hydrochloride3 |
Inj 25 mg vial, 1 vial pack |
$271.35 |
$77.00 |
Ribomustin |
5% |
1 April 2021 |
1 September 2021 |
|
|
Bendamustine hydrochloride3 |
Inj 100 mg vial, 1 vial pack |
$1,085.38 |
$308.00 |
Ribomustin (Janssen Cilag) |
5% |
1 April 2021 |
1 September 2021 |
|
|
Betamethasone dipropionate with calcipotriol |
Gel 500 mcg with calcipotriol 50 mcg per g, 60 g tube |
$52.24 |
$39.35 |
Daivobet (LEO Pharma) |
5% |
1 July 2021 |
1 December 2021 |
|
|
Betamethasone dipropionate with calcipotriol |
Oint 500 mcg with calcipotriol 50 mcg per g, 30 g tube |
$19.95 |
$15.90 |
Daivobet (LEO Pharma) |
5% |
1 July 2021 |
1 December 2021 |
|
|
Bisacodyl |
Suppos 10 mg,10 suppository |
$3.74 |
$3.69 |
Lax-Suppositories (AFT) |
5% |
1 July 2021 |
1 December 2021 |
|
|
Bosentan |
Tab 62.5 mg, 60 tablet, blister pack |
$141.00 |
$119.85 |
Bosentan Dr Reddy’s |
5% |
1 July 2021 |
1 December 2021 |
|
|
Bosentan |
Tab 125 mg, 60 tablet, blister pack |
$141.00 |
$119.85 |
Bosentan Dr Reddy’s |
5% |
1 July 2021 |
1 December 2021 |
|
|
Candesartan cilexetil |
Tab 4 mg, 90 tablet, bottle |
$1.90 |
$2.00 |
Candestar (Mylan) |
5% |
1 July 2021 |
1 December 2021 |
|
|
Candesartan cilexetil |
Tab 8 mg, 90 tablet, bottle |
$2.28 |
$2.28 |
Candestar (Mylan) |
5% |
1 July 2021 |
1 December 2021 |
|
|
Candesartan cilexetil |
Tab 16 mg, 90 tablet, bottle |
$3.67 |
$3.31 |
Candestar (Mylan) |
5% |
1 July 2021 |
1 December 2021 |
|
|
Candesartan cilexetil |
Tab 32 mg, 90 tablet, bottle |
$6.39 |
$5.26 |
Candestar (Mylan) |
5% |
1 July 2021 |
1 December 2021 |
|
|
Ciprofloxacin2 |
Eye drops 0.3%, 5 ml dropper bottle |
$12.15 |
$9.73 |
Ciprofloxacin Teva (Teva) |
5% |
1 June 2021 |
1 November 2021 |
|
|
Crotamiton |
Crm 10%, 20 g tube |
$3.29 |
$3.29 |
Itch-Soothe (AFT) |
5% |
1 July 2021 |
1 December 2021 |
|
|
Cyclizine hydrochloride |
Tab 50 mg, 10 tablet, blister pack |
$0.55 |
$0.49 |
Nausicalm (AFT) |
5% |
1 July 2021 |
1 December 2021 |
|
|
Cyclophosphamide |
Inj 1 g vial, 1 vial pack |
$35.65 |
$35.65 |
Endoxan (Baxter) |
5% |
1 July 2021 |
1 December 2021 |
|
|
Cyclophosphamide |
Inj 2 g vial, 1 vial pack |
$71.25 |
$71.25 |
Endoxan (Baxter) |
5% |
1 July 2021 |
1 December 2021 |
|
|
Dobutamine |
Inj 12.5 mg per ml, 20 ml ampoule, 5 ampoule pack |
$61.13 |
$61.13 |
Dobutamine-hameln |
5% |
1 July 2021 |
1 December 2021 |
|
|
Fluorouracil sodium |
Crm 5%, 20 g tube |
$7.95 |
$6.95 |
Efudix (iNova) |
5% |
1 July 2021 |
1 December 2021 |
|
|
Fluticasone propionate |
Metered aqueous nasal spray, 50 mcg per dose, 120 dose bottle |
$1.98 |
$1.98 |
Flixonase Hayfever |
5% |
1 July 2021 |
1 December 2021 |
|
|
Glyceryl trinitrate |
Oint 0.2%, 30 g tube |
$22.00 |
$22.00 |
Rectogesic |
5% |
1 April 2021 |
1 September 2021 |
|
|
Hydrocortisone |
Inj 100 mg vial, 1 vial pack |
$5.30 |
$4.38 |
Solu-Cortef (Pfizer) |
5% |
1 June 2021 |
1 November 2021 |
|
|
Hydrocortisone butyrate |
Oint 0.1%, 100 g tube |
$13.70 |
$10.28 |
Locoid (LEO Pharma) |
5% |
1 July 2021 |
1 December 2021 |
|
|
Hydrocortisone butyrate |
Milky emul 0.1%, 100 ml bottle |
$13.70 |
$12.33 |
Locoid Crelo |
5% |
1 July 2021 |
1 December 2021 |
|
|
Hydrocortisone butyrate |
Scalp lotn 0.1%, 100 ml bottle |
$7.30 |
$6.57 |
Locoid (LEO Pharma) |
5% |
1 July 2021 |
1 December 2021 |
|
|
Hydrocortisone with miconazole |
Crm 1% with miconazole nitrate 2%, 15 g tube |
$2.00 |
$1.89 |
Micreme H (Mylan) |
5% |
1 July 2021 |
1 December 2021 |
|
|
Lansoprazole |
Cap 15 mg, 100 capsule, bottle |
$4.58 |
$4.20 |
Lanzol Relief (Mylan) |
5% |
1 July 2021 |
1 December 2021 |
|
|
Lansoprazole |
Cap 30 mg, 100 capsule, bottle |
$5.41 |
$5.26 |
Lanzol Relief (Mylan) |
5% |
1 July 2021 |
1 December 2021 |
|
|
Linezolid |
Tab 600 mg, 10 tablet, blister pack |
$553.77 |
$276.89 |
Zyvox (Pfizer) |
5% |
1 July 2021 |
1 December 2021 |
|
|
Lorazepam |
Tab 1 mg, 250 tablet, bottle |
$9.72 |
$9.72 |
Ativan (Aspen Pharma) |
5% |
1 July 2021 |
1 December 2021 |
|
|
Lorazepam |
Tab 2.5 mg, 100 tablet, bottle |
$12.50 |
$12.50 |
Ativan (Aspen Pharma) |
5% |
1 July 2021 |
1 December 2021 |
|
|
Miconazole |
Oral gel 20 mg per g, 40 g tube |
$4.74 |
$4.74 |
Decozol (AFT) |
5% |
1 July 2021 |
1 December 2021 |
|
|
Neostigmine metisulfate with glycopyrronium bromide |
Inj 2.5 mg with glycopyrronium |
$26.13 |
$26.13 |
Max Health (Max Health) |
5% |
1 July 2021 |
1 December 2021 |
|
|
Oxycodone hydrochloride |
Cap immediate-release 5 mg, |
$1.88 |
$1.88 |
OxyNorm (MundiPharma) |
5% |
1 July 2021 |
1 December 2021 |
|
|
Oxycodone hydrochloride |
Cap immediate-release 10 mg, |
$3.32 |
$3.32 |
OxyNorm (MundiPharma) |
5% |
1 July 2021 |
1 December 2021 |
|
|
Oxycodone hydrochloride |
Cap immediate-release 20 mg, |
$5.81 |
$5.23 |
OxyNorm (MundiPharma) |
5% |
1 July 2021 |
1 December 2021 |
|
|
Oxycodone hydrochloride |
Oral liq 5 mg per 5 ml, 250 ml bottle |
$11.20 |
$11.20 |
OxyNorm (MundiPharma) |
5% |
1 April 2021 |
1 September 2021 |
|
|
Prednisolone |
Oral liq 5 mg per ml,30 ml bottle |
$6.00 |
$6.00 |
Redipred |
5% |
1 July 2021 |
1 December 2021 |
|
|
Riluzole |
Tab 50 mg, 56 tablet, blister pack |
$130.00 |
$130.00 |
Rilutek (Sanofi) |
5% |
1 July 2021 |
1 December 2021 |
|
|
Sodium fusidate [fusidic acid] |
Crm 2%, 5 g tube |
$1.59 |
$1.59 |
Foban (AFT) |
5% |
1 July 2021 |
1 December 2021 |
|
|
Sodium fusidate [fusidic acid] |
Oint 2%, 5 g tube |
$1.59 |
$1.59 |
Foban (AFT) |
5% |
1 July 2021 |
1 December 2021 |
|
|
Sodium hyaluronate |
Eye drops 1 mg per ml, 10 ml |
$22.00 |
$13.85 |
Hylo-Fresh (AFT) |
5% |
1 August 2021 |
1 January 2022 |
|
|
Solifenacin succinate |
Tab 5 mg, 30 tablet, blister pack |
$3.00 |
$2.05 |
Solifenacin Mylan (Mylan) |
5% |
1 July 2021 |
1 December 2021 |
|
|
Solifenacin succinate |
Tab 10 mg, 30 tablet, blister pack |
$5.50 |
$3.72 |
Solifenacin Mylan (Mylan) |
5% |
1 July 2021 |
1 December 2021 |
|
|
Tranexamic acid |
Inj 100 mg per ml, 5 ml ampoule, |
$6.95 |
$5.95 |
Tranexamic-AFT (AFT) |
5% |
1 July 2021 |
1 December 2021 |
|
|
Tranexamic acid |
Inj 100 mg per ml, 10 ml ampoule, |
$10.95 |
$5.95 |
Tranexamic-AFT (AFT) |
5% |
1 July 2021 |
1 December 2021 |
|
|
Valganciclovir |
Tab 450 mg, 60 tablet, bottle |
$225.00 |
$132.00 |
Valganciclovir Mylan (Mylan) |
5% |
1 July 2021 |
1 December 2021 |
|
|
Zoledronic acid |
Inj 4 mg per 5 ml, vial, 1 vial pack |
$38.03 |
$18.00 |
Zoledronic Acid (Mylan) |
5% |
1 July 2021 |
1 December 2021 |
|
|
2 This product will be supplied at the Price from the 1st day of the month prior to the listing date, as per Schedule 6, clause 3.1 (b)(II) of the 2020/21 Invitation To Tender. 3 The price and subsidy of bendamustine hydrochloride (PCT only – Specialist) in Section B of the Pharmaceutical Schedule will also be amended to the above prices from 1 April 2021. The subsidy of bendamustine hydrochloride (Baxter) inj 1 mg for ECP in Section B of the Pharmaceutical Schedule will also be amended from $11.40 per 1 mg to $3.23 per 1 mg from 1 April 2021. |
||||||||
4. Tenders awarded to pharmaceuticals where at least one other brand is listed.
The decisions were as follows:
|
Chemical name |
Presentation; |
Current pack price |
New pack price |
Principal Supply brand |
DV limit |
Listing date |
Principal Supply date |
Brand (Supplier) affected by delisting |
|---|---|---|---|---|---|---|---|---|
|
Acarbose |
Tab 50 mg, 90 tablet, blister pack |
$10.47 |
$8.95 |
Accarb (Mylan) |
5% |
1 July 2021 |
1 December 2021 |
Glucobay (Bayer) |
|
Acarbose |
Tab 100 mg, 90 tablet, blister pack |
$20.23 |
$15.29 |
Accarb (Mylan) |
5% |
1 July 2021 |
1 December 2021 |
Glucobay (Bayer) |
|
Amoxicillin with clavulanic acid |
Inj 500 mg with clavulanic |
$28.18 |
$17.50 |
Amoxiclav multichem (Multichem) |
5% |
1 July 2021 |
1 December 2021 |
m-Amoxiclav (Multichem) |
|
Amoxicillin with clavulanic acid |
Inj 1,000 mg with clavulanic |
$43.30 |
$26.90 |
Amoxiclav multichem (Multichem) |
5% |
1 July 2021 |
1 December 2021 |
m-Amoxiclav (Multichem) |
5. Tenders awarded to currently listed pharmaceuticals where no brand is listed.
The decisions were as follows:
|
Chemical name |
Presentation; |
New |
Principal Supply brand |
DV Limit |
Listing date |
Principal Supply date |
|---|---|---|---|---|---|---|
|
Brinzolamide |
Eye drops 1%, 5 ml dropper bottle |
$7.30 |
Azopt (Novartis) |
5% |
1 April 2021 |
1 September 2021 |
|
Lithium carbonate |
Tab long-acting 400 mg, 100 tablet, blister pack |
$72.00 |
Priadel (Clinect) |
5% |
1 April 2021 |
1 September 2021 |
Tender declines - Products where no tender is to be awarded for Principal Supply Status
PHARMAC has resolved not to award tenders for Principal Supply Status for the following products listed in:
- the 2020/21 Invitation to Tender, dated 2 November 2020
2020/21 Invitation to Tender
|
Chemical name |
Line item |
|---|---|
|
Alpha Tocopheryl Acetate |
Oral liq |
|
Alteplase |
Inj 10 mg |
|
Alteplase |
Inj 2 mg |
|
Alteplase |
Inj 50 mg |
|
Baclofen |
Inj 0.05 mg per ml, 1 ml |
|
Baclofen |
Oral liq |
|
Bumetanide |
Tab 1 mg |
|
Calcipotriol |
Soln 50 mcg per ml (pack size 30 ml or greater) |
|
Carboprost |
Inj 250 mcg per ml, 1ml |
|
Cefoxitin |
Inj 1 g |
|
Cytarabine |
Inj 100 mg |
|
Cytarabine |
Inj 2 g |
|
Ethinyloestradiol |
Tab 10 mcg |
|
Filgrastim |
Inj 300 mcg per ml, 1 ml vial |
|
Furosemide |
Tab 500 mg |
|
Ganciclovir |
Inj 500 mg |
|
Hydrocortisone Acetate |
Rectal foam 10 - 15% |
|
Hydrocortisone Butyrate |
Cream 0.1% (pack size 30 g or less) |
|
Hydrogen Peroxide |
Crm 1% |
|
Hydrogen Peroxide |
Crm 2% |
|
Lithium carbonate |
Cap immediate-release 250 mg |
|
Lithium Carbonate |
Tab immediate-release 250 mg |
|
Lorazepam |
Tab 0.5 mg |
|
Metronidazole |
Oral liq benzoate 200 mg per 5 ml |
|
Metronidazole |
Suppos 500 mg |
|
Nifedipine |
Tab long-acting 10 mg |
|
Nifedipine |
Tab long-acting 20 mg |
|
Nifedipine |
Tab long-acting 30 mg |
|
Nifedipine |
Tab long-acting 60 mg |
|
Oestradiol |
TDDS 100 mcg per day |
|
Oestradiol |
TDDS 25 mcg per day |
|
Oestradiol |
TDDS 50 mcg per day |
|
Oestradiol |
TDDS 75 mcg per day |
|
Oestradiol valerate |
Tab 1 mg |
|
Oestradiol valerate |
Tab 2 mg |
|
Olanzapine |
Inj 210 mg |
|
Olanzapine |
Inj 300 mg |
|
Olanzapine |
Inj 405 mg |
|
Pancuronium bromide |
Inj 2 mg per ml, 2 ml |
|
Pazopanib (current access) |
Tab 200 mg |
|
Pazopanib (current access) |
Tab 400 mg |
|
Pazopanib (widened access) |
Tab 200 mg |
|
Pazopanib (widened access) |
Tab 400 mg |
|
Testosterone |
Transdermal patch 2.5 mg |
|
Testosterone |
Transdermal patch 5 mg |
|
Testosterone undecanoate |
Cap 40 mg |
If you have any queries regarding this notification, please contact PHARMAC on 0800 66 00 50.For products included in the 2018/19 and 2019/20 Invitation to Tender where no announcement has yet been made, either a decision is still pending or is provisional, subject to the product gaining market approval and being available to supply, and subject to PHARMAC Board (or its delegate) approval. We will keep you informed of any updates regarding such tender products as decisions are made.